Pfizer (NYSE: PFE) recently provided its second-quarter update. In this Motley Fool Live video recorded on July 28, Motley Fool contributors Keith Speights and Brian Orelli discuss what really mattered in Pfizer's Q2 results. Keith Speights: Well in our last few minutes Brian, let's touch on the big earnings story from this morning and it has to do with Pfizer.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting